EVT 

$0.000000
11
+$0.00+0% Monday 00:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Sep 26
$0.17
Mar 26
$0.13
Sep 25
$0.14
Mar 25
$0.10
Sep 24
$0.14
10Y Growth
-2.01%
5Y Growth
N/A
3Y Growth
41.9%
1Y Growth
11.11%

Earnings

23AugExpected
Q2 2023
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
0.02
0.1
0.18
0.25
Expected EPS
0.08556812171851029
Actual EPS
0.08684767750034876

Financials

2.72%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
761.45MRevenue
20.74MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EVHEF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap304.1B
Novartis is a global healthcare company that competes with EVT in the pharmaceutical and biotech sectors, particularly in drug discovery and development.
Pfizer
PFE
Mkt Cap162.16B
Pfizer is a large pharmaceutical company that competes with EVT in developing and commercializing drugs for various therapeutic areas.
Merck
MRK
Mkt Cap370.89B
Merck is a leading pharmaceutical company that competes with EVT in the research, development, and manufacturing of pharmaceuticals.
GSK
GSK
Mkt Cap99.96B
GlaxoSmithKline is a global healthcare company that competes with EVT in the pharmaceutical and vaccine markets.
Johnson & Johnson
JNJ
Mkt Cap663.28B
Johnson & Johnson is a diversified healthcare company that competes with EVT across several segments, including pharmaceuticals.
Abbvie
ABBV
Mkt Cap453.19B
AbbVie is a biopharmaceutical company that competes with EVT in developing advanced therapies for complex diseases.
AMGEN
AMGN
Mkt Cap236.38B
Amgen is a biotechnology company that competes with EVT in the discovery, development, and delivery of innovative medicines.
Bristol-Myers Squibb
BMY
Mkt Cap136.49B
Bristol Myers Squibb is a global biopharmaceutical company that competes with EVT in developing novel medicines for various diseases.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a healthcare company that competes with EVT in pharmaceuticals and diagnostics, focusing on oncology, immunology, and infectious diseases.
Sanofi
SNY
Mkt Cap106.01B
Sanofi is a global healthcare leader that competes with EVT in providing therapeutic solutions in a wide range of medical fields.

About

EVT Limited engages in the entertainment business in Australia, New Zealand, Singapore, and Germany. The company operates through Entertainment, Entertainment Germany, Hotels and Resorts, Thredbo Alpine Resort, and Property and Other Investments segments. It is involved in the cinema and outdoor cinema operations under the Event Cinemas, BCC Cinemas, Rialto Cinemas, Embassy Theatre, CineStar, Moonlight Cinema, and Skyline Drive In names; operation of spas and golf courses under the SpaQ, Ubika Spa, Thredbo, and Rydges names; and bar, restaurant, and theatre operations. The company also owns, operates, and manages hotels and resorts under the QT, Rydges, Atura, LyLo, and Thredbo Alpine names. In addition, it engages in the property investment and development activities; property rental activities; and hotel management, and media and entertainment technology businesses. The company was formerly known as Event Hospitality & Entertainment Limited and changed its name to EVT Limited in October 2022. The company was founded in 1910 and is headquartered in Sydney, Australia.
Show more...
CEO
Country
Australia
ISIN
AU000000EVT1
WKN
000A2ACRX

Listings

0 Comments

Share your thoughts

FAQ

What is EVT stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange EVT stocks are traded under the ticker EVHEF.
When is the next EVT earnings date?
EVT is going to release the next earnings report on February 18, 2027.
What were EVT earnings last quarter?
EVHEF earnings for the last quarter are 0.06 USD per share, whereas the estimation was 0.06 USD resulting in a +1.5% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is EVT revenue for the last year?
EVT revenue for the last year amounts to 761.45M USD.
What is EVT net income for the last year?
EVHEF net income for the last year is 20.74M USD.
Does EVT pay dividends?
Yes, EVHEF dividends are paid semi-annual. The last dividend per share was 0.13 USD. As of today, Dividend Yield (FWD)% is 0%.
In which sector is EVT located?
EVT operates in the Other sector.
When did EVT complete a stock split?
EVT has not had any recent stock splits.